A synthetic mRNA cell reprogramming method using CYCLIN D1 promotes DNA repair, generating improved genetically stable human induced pluripotent stem cells.

A key challenge for clinical application of induced pluripotent stem cells (iPSC) to accurately model and treat human pathologies depends on developing a method to generate genetically stable cells to reduce long-term risks of cell transplant therapy. Here, we hypothesized that CYCLIN D1 repairs DNA...

ver descrição completa

Detalhes bibliográficos
Autores: Alvarez-Palomo, Ana Belén, Requena-Osete, Jordi, Delgado-Morales, Raul, Moreno-Manzano, Victoria, Grau-Bove, Carme, Tejera, Agueda M, Otero, Manel Juan, Barrot, Carme, Santos-Barriopedro, Irene, Vaquero, Alejandro, Mezquita-Pla, Jovita, Moran, Sebastian, Naya, Carlos Hobeich, Garcia-Martínez, Iris, Pérez, Francisco Vidal, Blasco, MA, Esteller, Manel, Edel, Michael J
Formato: artículo
Fecha de publicación:2021
País:España
Recursos:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/19030
Acesso em linha:http://hdl.handle.net/20.500.12105/19030
Access Level:acceso abierto
Palavra-chave:Induced Pluripotent Stem Cells
Animals
Cell Differentiation
Cellular Reprogramming
Cyclin D1
DNA Repair
Humans
Mice
RNA, Messenger
id ES_2ada7224169d7e9352b5efb5fb37889c
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/19030
network_acronym_str ES
network_name_str España
repository_id_str
spelling A synthetic mRNA cell reprogramming method using CYCLIN D1 promotes DNA repair, generating improved genetically stable human induced pluripotent stem cells.Alvarez-Palomo, Ana BelénRequena-Osete, JordiDelgado-Morales, RaulMoreno-Manzano, VictoriaGrau-Bove, CarmeTejera, Agueda MOtero, Manel JuanBarrot, CarmeSantos-Barriopedro, IreneVaquero, AlejandroMezquita-Pla, JovitaMoran, SebastianNaya, Carlos HobeichGarcia-Martínez, IrisPérez, Francisco VidalBlasco, MAEsteller, ManelEdel, Michael JInduced Pluripotent Stem CellsAnimalsCell DifferentiationCellular ReprogrammingCyclin D1DNA RepairHumansMiceRNA, MessengerA key challenge for clinical application of induced pluripotent stem cells (iPSC) to accurately model and treat human pathologies depends on developing a method to generate genetically stable cells to reduce long-term risks of cell transplant therapy. Here, we hypothesized that CYCLIN D1 repairs DNA by highly efficient homologous recombination (HR) during reprogramming to iPSC that reduces genetic instability and threat of neoplastic growth. We adopted a synthetic mRNA transfection method using clinically compatible conditions with CYCLIN D1 plus base factors (OCT3/4, SOX2, KLF4, LIN28) and compared with methods that use C-MYC. We demonstrate that CYCLIN D1 made iPSC have (a) lower multitelomeric signal, (b) reduced double-strand DNA breaks, (c) correct nuclear localization of RAD51 protein expression, and (d) reduced single-nucleotide polymorphism (SNP) changes per chromosome, compared with the classical reprogramming method using C-MYC. CYCLIN D1 iPSC have reduced teratoma Ki67 cell growth kinetics and derived neural stem cells successfully engraft in a hostile spinal cord injury (SCI) microenvironment with efficient survival, differentiation. We demonstrate that CYCLIN D1 promotes double-stranded DNA damage repair predominantly through HR during cell reprogramming to efficiently produce iPSC. CYCLIN D1 reduces general cell stress associated with significantly lower SIRT1 gene expression and can rescue Sirt1 null mouse cell reprogramming. In conclusion, we show synthetic mRNA transfection of CYCLIN D1 repairs DNA during reprogramming resulting in significantly improved genetically stable footprint in human iPSC, enabling a new cell reprogramming method for more accurate and reliable generation of human iPSC for disease modeling and future clinical applications.Oxford University PressFundación La Marató TV3Government of Catalonia (España)Worldwide Cancer ResearchFundación Banco SantanderInstituto de Salud Carlos IIIUniversity of Barcelona (España)Agencia Estatal de Investigación (España)Ministerio de Economía e Innovación (España)20242024-03-2120212021-07-0120212021-07-01journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/20.500.12105/19030reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/190302026-06-12T12:43:37Z
dc.title.none.fl_str_mv A synthetic mRNA cell reprogramming method using CYCLIN D1 promotes DNA repair, generating improved genetically stable human induced pluripotent stem cells.
title A synthetic mRNA cell reprogramming method using CYCLIN D1 promotes DNA repair, generating improved genetically stable human induced pluripotent stem cells.
spellingShingle A synthetic mRNA cell reprogramming method using CYCLIN D1 promotes DNA repair, generating improved genetically stable human induced pluripotent stem cells.
Alvarez-Palomo, Ana Belén
Induced Pluripotent Stem Cells
Animals
Cell Differentiation
Cellular Reprogramming
Cyclin D1
DNA Repair
Humans
Mice
RNA, Messenger
title_short A synthetic mRNA cell reprogramming method using CYCLIN D1 promotes DNA repair, generating improved genetically stable human induced pluripotent stem cells.
title_full A synthetic mRNA cell reprogramming method using CYCLIN D1 promotes DNA repair, generating improved genetically stable human induced pluripotent stem cells.
title_fullStr A synthetic mRNA cell reprogramming method using CYCLIN D1 promotes DNA repair, generating improved genetically stable human induced pluripotent stem cells.
title_full_unstemmed A synthetic mRNA cell reprogramming method using CYCLIN D1 promotes DNA repair, generating improved genetically stable human induced pluripotent stem cells.
title_sort A synthetic mRNA cell reprogramming method using CYCLIN D1 promotes DNA repair, generating improved genetically stable human induced pluripotent stem cells.
dc.creator.none.fl_str_mv Alvarez-Palomo, Ana Belén
Requena-Osete, Jordi
Delgado-Morales, Raul
Moreno-Manzano, Victoria
Grau-Bove, Carme
Tejera, Agueda M
Otero, Manel Juan
Barrot, Carme
Santos-Barriopedro, Irene
Vaquero, Alejandro
Mezquita-Pla, Jovita
Moran, Sebastian
Naya, Carlos Hobeich
Garcia-Martínez, Iris
Pérez, Francisco Vidal
Blasco, MA
Esteller, Manel
Edel, Michael J
author Alvarez-Palomo, Ana Belén
author_facet Alvarez-Palomo, Ana Belén
Requena-Osete, Jordi
Delgado-Morales, Raul
Moreno-Manzano, Victoria
Grau-Bove, Carme
Tejera, Agueda M
Otero, Manel Juan
Barrot, Carme
Santos-Barriopedro, Irene
Vaquero, Alejandro
Mezquita-Pla, Jovita
Moran, Sebastian
Naya, Carlos Hobeich
Garcia-Martínez, Iris
Pérez, Francisco Vidal
Blasco, MA
Esteller, Manel
Edel, Michael J
author_role author
author2 Requena-Osete, Jordi
Delgado-Morales, Raul
Moreno-Manzano, Victoria
Grau-Bove, Carme
Tejera, Agueda M
Otero, Manel Juan
Barrot, Carme
Santos-Barriopedro, Irene
Vaquero, Alejandro
Mezquita-Pla, Jovita
Moran, Sebastian
Naya, Carlos Hobeich
Garcia-Martínez, Iris
Pérez, Francisco Vidal
Blasco, MA
Esteller, Manel
Edel, Michael J
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Fundación La Marató TV3
Government of Catalonia (España)
Worldwide Cancer Research
Fundación Banco Santander
Instituto de Salud Carlos III
University of Barcelona (España)
Agencia Estatal de Investigación (España)
Ministerio de Economía e Innovación (España)

dc.subject.none.fl_str_mv Induced Pluripotent Stem Cells
Animals
Cell Differentiation
Cellular Reprogramming
Cyclin D1
DNA Repair
Humans
Mice
RNA, Messenger
topic Induced Pluripotent Stem Cells
Animals
Cell Differentiation
Cellular Reprogramming
Cyclin D1
DNA Repair
Humans
Mice
RNA, Messenger
description A key challenge for clinical application of induced pluripotent stem cells (iPSC) to accurately model and treat human pathologies depends on developing a method to generate genetically stable cells to reduce long-term risks of cell transplant therapy. Here, we hypothesized that CYCLIN D1 repairs DNA by highly efficient homologous recombination (HR) during reprogramming to iPSC that reduces genetic instability and threat of neoplastic growth. We adopted a synthetic mRNA transfection method using clinically compatible conditions with CYCLIN D1 plus base factors (OCT3/4, SOX2, KLF4, LIN28) and compared with methods that use C-MYC. We demonstrate that CYCLIN D1 made iPSC have (a) lower multitelomeric signal, (b) reduced double-strand DNA breaks, (c) correct nuclear localization of RAD51 protein expression, and (d) reduced single-nucleotide polymorphism (SNP) changes per chromosome, compared with the classical reprogramming method using C-MYC. CYCLIN D1 iPSC have reduced teratoma Ki67 cell growth kinetics and derived neural stem cells successfully engraft in a hostile spinal cord injury (SCI) microenvironment with efficient survival, differentiation. We demonstrate that CYCLIN D1 promotes double-stranded DNA damage repair predominantly through HR during cell reprogramming to efficiently produce iPSC. CYCLIN D1 reduces general cell stress associated with significantly lower SIRT1 gene expression and can rescue Sirt1 null mouse cell reprogramming. In conclusion, we show synthetic mRNA transfection of CYCLIN D1 repairs DNA during reprogramming resulting in significantly improved genetically stable footprint in human iPSC, enabling a new cell reprogramming method for more accurate and reliable generation of human iPSC for disease modeling and future clinical applications.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-07-01
2021
2021-07-01
2024
2024-03-21
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12105/19030
url http://hdl.handle.net/20.500.12105/19030
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Oxford University Press
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv reponame:Repisalud
instname:Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
reponame_str Repisalud
collection Repisalud
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869405098428334080
score 15,812455